Taking the Next Step GLP-1 medications have transformed Type 2 diabetes treatment by delivering comprehensive metabolic improvement beyond what previous options could achieve
Unlike older GHRPs such as GHRP-6, ipamorelin produces a clean GH pulse with a favorable safety profile in early human studies [2]
Research shows approximately 50-70% of patients experience weight regain within one year of stopping GLP-1, while others maintain results long-term
However, GLP1R agonists produce a variety of effects in the brain as well, making efforts to increase the ability of such drugs to cross the blood-brain barrier of high interest
I was on WeightWatchers many times, probably starting in my early 20s
16 Through both proactive and ongoing individualized therapy, pharmacists play a central role in mitigating and preventing the GI AEs associated with GLP-1 RA therapy